Uncertainty & Complexity

Digital twins—computational models designed to simulate the biological behavior of an individual patient—have emerged as one of the most alluring...

Glucagon-like peptide-1 receptor agonists—marketed most visibly as Ozempic and Wegovy—have moved from endocrinology clinics into popular culture with unusual velocity....

Between 2010 and 2015, smartphones became nearly ubiquitous among adolescents in the United States. By 2022, the Pew Research Center...

Seed oils, emulsifiers, stabilizers, preservatives—once obscure inputs in a globalized food system—now serve as ideological flashpoints. The term “ultra-processed food,”...

Mental health awareness—once relegated to advocacy days and reluctant disclosures—now sits inside earnings calls, human resources dashboards, and federal appropriations....

Longevity science—once confined to academic gerontology and speculative Silicon Valley forums—has entered capital markets and clinical practice with unusual momentum....

Across clinics and corporate offices, a growing number of Americans identify with chronic conditions that resist straightforward measurement: long COVID,...

Health misinformation has become less a discrete problem than a structural feature of the digital environment. Social platforms distribute medical...

The opioid crisis in the United States has entered a synthetic phase defined less by prescription volume than by the...

In recent weeks, Parkinson’s disease has returned to the center of scientific and policy discourse as early-phase clinical trials implant...

Behavioral health utilization in the United States has climbed steadily over the past several years, with particularly sharp increases in...

Intermittent fasting—variously packaged as time-restricted eating, 5:2 cycling, or extended caloric abstention—has occupied a curious space in metabolic discourse: both...